Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.20.2
NET LOSS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2020
NET LOSS PER SHARE  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

September 30, 

 

    

2020

    

2019

Warrants

 

17,937,766

 

9,268,352

Preferred shares as convertible into common stock

 

537,500

 

537,500

Stock options

 

1,184,464

 

610,714

Non-vested restricted stock

 

—

 

9,334

Total potentially dilutive shares

 

19,659,730

 

10,425,900